Crossmark

Lack of viral clearance by the combination of hydroxychloroquine and azithromycin or lopinavir and ritonavir in SARS-CoV-2-related acute respiratory distress syndrome

Crossref DOI link: https://doi.org/10.1186/s13613-020-00678-4

Published Online: 2020-05-24

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hraiech, Sami http://orcid.org/0000-0003-4652-1664
Bourenne, Jérémy

Kuteifan, Khaldoun

Helms, Julie

Carvelli, Julien

Gainnier, Marc

Meziani, Ferhat

Papazian, Laurent
License Information

Text and Data Mining valid from 2020-05-24

Version of Record valid from 2020-05-24
More Information

Article History

Received: 27 April 2020

Accepted: 13 May 2020

First Online: 24 May 2020

Ethics approval and consent to participate

: Patients and their relatives were informed of the possibility of the use of medical data for retrospective studies and did not manifest opposition.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below